Extracorporeal photopheresis induces NETosis in neutrophils derived from patients with chronic graft-vs-host disease

被引:1
|
作者
Goldberg, Idan [1 ,2 ,3 ,8 ]
Granot, Galit [4 ]
Telerman, Alona [4 ]
Partouche, Shirly [4 ]
Shochat, Tzippy [5 ]
Halperin, Erez [1 ]
Gafter-Gvili, Anat [1 ,2 ,6 ]
Shargian, Liat [1 ,2 ]
Yeshurun, Moshe [1 ,2 ]
Raanani, Pia [1 ,2 ]
Wolach, Ofir [1 ,2 ]
Yahalom, Vered [2 ,7 ]
机构
[1] Rabin Med Ctr, Beilinson Hosp, Inst Hematol, Davidoff Canc Ctr, Petah Tiqwa, Israel
[2] Tel Aviv Univ, Sackler Sch Med, Tel Aviv, Israel
[3] Rabin Med Ctr, Beilinson Hosp, Dept Internal Med F Recanati, Petah Tiqwa, Israel
[4] Rabin Med Ctr, Beilinson Hosp, Felsenstein Med Res Ctr, Petah Tiqwa, Israel
[5] Rabin Med Ctr, Beilinson Hosp, Stat Consulting Unit, Petah Tiqwa, Israel
[6] Rabin Med Ctr, Beilinson Hosp, Dept Internal Med, Petah Tiqwa, Israel
[7] Rabin Med Ctr, Blood Serv & Apheresis Inst, Petah Tiqwa, Israel
[8] Rabin Med Ctr, Inst Hematol, 39 Jabotinsky St, IL-4941492 Petah Tiqwa, Israel
关键词
extracorporeal photopheresis (ECP); graft vs host disease (GVHD); neutrophil extracellular traps (NETs); REGULATORY T-CELLS; ECP;
D O I
10.1002/jca.22073
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Introduction: Extracorporeal photopheresis (ECP) is considered an effective treatment for patients with chronic graft vs host disease (cGVHD) and demonstrates efficacy in ameliorating GVHD. The mechanism by which ECP acts against cGVHD is not fully understood. Preliminary observations have hinted at the potential involvement of neutrophil extracellular traps (NETs) formation in the pathogenesis of cGVHD. We aimed to assess the influence of ECP on the formation of NETs in patients with cGVHD as a potential mechanism in this setting.Methods: Patients treated with ECP for cGVHD at the Rabin Medical Center were included in this study. Blood samples were obtained at three different time points: before starting an ECP cycle, at the end of the first day of treatment, and 24 h following the initiation of the ECP treatment cycle. Neutrophils were harvested from all blood samples. NET formation was assessed by measurement of NET-bound specific neutrophil elastase activity and by immunofluorescence staining.Results: Six patients (two females and four males) with cGVHD were included in the study. We observed a significant increase in NET formation among all six patients following ECP. Net-bound specific neutrophil elastase activity was elevated from a median value of 2.23 mU/mL (interquartile range [IQR] 2.06-2.47 mU/mL) at baseline to a median value of 13.06 mU/mL (IQR 10.27-15.97 mU/mL) immediately after the treatment and to a peak median value of 14.73 mU/mL (IQR 9.6-22.38 mU/mL) 24 h following the initiation of the ECP cycle. A qualitative assessment of NET formation using immunofluorescence staining has demonstrated markedly increased expression of citrullinated histone H3, a marker of NET formation, following ECP treatment.Conclusions: Our preliminary data indicate that ECP induces NET formation among patients with cGVHD. The contribution of increased NET formation to the therapeutic effect of cGVHD should be further investigated.
引用
收藏
页码:615 / 621
页数:7
相关论文
共 50 条
  • [41] Positive Effect of Extracorporeal Photopheresis In Reducing Immunosuppression in Patients with Chronic Graft Versus Host Disease
    Dignan, Fiona L.
    Greenblatt, Danielle
    Cox, Michael
    Shaw, Bronwen E.
    Scarisbrick, Julia J.
    BLOOD, 2010, 116 (21) : 1417 - 1417
  • [42] Rituximab effective in treating chronic graft-vs-host disease
    不详
    ONCOLOGY-NEW YORK, 2006, 20 (05): : 475 - 475
  • [43] PUVA THERAPY FOR CHRONIC CUTANEOUS GRAFT-VS-HOST DISEASE
    JAMPEL, RM
    FARMER, ER
    VOGELSANG, GB
    WINGARD, J
    SANTOS, GW
    MORISON, WL
    ARCHIVES OF DERMATOLOGY, 1991, 127 (11) : 1673 - 1678
  • [44] The isomorphic response in morphealike chronic graft-vs-host disease
    Patel, Asha R.
    Pavletic, Steven Z.
    Turner, Maria L.
    Cowen, Edward W.
    ARCHIVES OF DERMATOLOGY, 2008, 144 (09) : 1229 - 1231
  • [45] ESOPHAGEAL ABNORMALITIES IN CHRONIC GRAFT-VS-HOST DISEASE IN MAN
    MCDONALD, GB
    SHULMAN, HM
    SULLIVAN, KM
    GASTROENTEROLOGY, 1979, 76 (05) : 1199 - 1199
  • [46] BULLOUS SCLERODERMALIKE CHANGES IN CHRONIC GRAFT-VS-HOST DISEASE
    HYMES, SR
    FARMER, ER
    BURNS, WH
    MORISON, WL
    TUTSCHKA, PJ
    WALTERS, LL
    SANTOS, GW
    ARCHIVES OF DERMATOLOGY, 1985, 121 (09) : 1189 - 1192
  • [47] Decoding Skin Involvement in Chronic Graft-vs-Host Disease
    Cowen, Edward W.
    JAMA DERMATOLOGY, 2019, 155 (07) : 777 - 778
  • [48] PREVENTION OF GRAFT-VS-HOST DISEASE
    WOODS, WG
    AMERICAN JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 1984, 6 (03): : 283 - 286
  • [49] Relief for Graft-vs-Host Disease
    Voelker, Rebecca
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2017, 318 (11): : 996 - 996
  • [50] Pilot study of a new online extracorporeal photopheresis system in patients with steroid refractory or dependent chronic graft vs host disease
    Radwanski, Katherine
    Burgstaler, Edwin
    Weitgenant, Jennifer
    Dale, Heather
    Heber, Cheryl
    Winters, Jeffrey
    JOURNAL OF CLINICAL APHERESIS, 2020, 35 (04) : 342 - 350